ATLASaTyr Pharma (ATYR) earnings date: Nov 5, 2026
aTyr Pharma (ATYR) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 5, 2026, after the close. Analysts expect EPS of -$4.40.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on ATYR
| Last price | $4.94 (+3,883.9%) |
|---|---|
| Normal 1-day range (±1σ) | ±6.2% |
| Earnings beat history | Beat the EPS estimate in 5 of the last 5 reports |
These figures come from the same calibrated model and valuation as the aTyr Pharma stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
aTyr Pharma reports on Nov 5, 2026. One email the day before, with ATLAS’s read on aTyr Pharma. You can switch it off at any time.
Alert me before ATYR reportsFree to start. Creating an account takes under a minute.
Notify me when aTyr Pharma reports
ATYR earnings at a glance
| Next report (confirmed) | Thu, Nov 5, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$4.40 |
| Last report | Aug 7, 2026 · Beat |
| Beat rate (last 5 reports) | 5 of 5 (100%) |
| Average EPS surprise | +31.4% |
| Average move around a report | ±7.8% (last 5) |
| Sector | Healthcare · Biotechnology |
aTyr Pharma earnings history: last 5 reports
aTyr Pharma last reported on Aug 7, 2026: EPS of -$4.40 against an estimate of -$5.00 (+12.0% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 7, 2026 | -$5.00 | -$4.40 | +12.0% | Beat | +5.4% |
| May 15, 2026 | -$5.50 | -$4.40 | +20.0% | Beat | -7.2% |
| May 4, 2026 | $0.78 | $0.87 | +11.5% | Beat | +1.0% |
| Mar 5, 2026 | -$7.00 | -$5.60 | +20.0% | Beat | -14.6% |
| Feb 6, 2026 | $3.18 | $6.15 | +93.4% | Beat | +11.0% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for ATYR
See the fair value, the probability range and the earnings history of aTyr Pharma on its ATLAS page.
aTyr Pharma (ATYR) stock analysisPlans from €3.99 a month.
aTyr Pharma earnings: frequently asked questions
When does aTyr Pharma (ATYR) report earnings?
aTyr Pharma is scheduled to report on Thursday, November 5, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for ATYR?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$4.40 per share (USD). Estimates can change before the report.
How often does ATYR beat earnings estimates?
Of its last 5 reports with a recorded result, aTyr Pharma beat the EPS estimate 5 times; the average surprise was +31.4%. Past results do not predict the next one.
How much does ATYR move around earnings?
Over its last 5 reports the stock moved an average of 7.8% (absolute, from the close before the report day to the close after it), and finished higher 3 of 5 times.
Did aTyr Pharma beat earnings estimates last quarter?
aTyr Pharma last reported on Aug 7, 2026: EPS of -$4.40 against an estimate of -$5.00 (+12.0% surprise), a beat.
How much does ATYR usually move in a day?
On a normal trading day the ATLAS model puts ATYR’s one-day range at about ±6.2%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 5, 2026
Educational information, not investment advice. Disclaimer